Biotech · Private company
Novaliq GmbH
Track this companyFree. Adds Novaliq GmbH to your Dealase workspace and tells you when its record changes.
Clinical trials71 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- CyclASol Ophthalmic SolutionPhase 3 · Dry Eye Disease (DED)ClinicalTrials.gov · fetched Nov 12, 2026
- CyclASol topical ocular, eye dropsPhase 3 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle topical ocular, eye dropsPhase 3 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Cyclosporine APhase 2 · Dry Eye SyndromesClinicalTrials.gov · fetched Nov 12, 2026
- NOV03Phase 2 · Dry Eye Disease (DED)ClinicalTrials.gov · fetched Nov 12, 2026
- Tacrolimus ophthalmic solutionPhase 2 · Non-infectious Anterior UveitisClinicalTrials.gov · fetched Nov 12, 2026
- Cyclosporine ophthalmic solution, 0.1%Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior UveitisPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 16, 2026ClinicalTrials.gov NCT07285070 · fetched Nov 12, 2026
- A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With CyclosporinePHASE4 · COMPLETED · started Apr 22, 2024ClinicalTrials.gov NCT06329661 · fetched Nov 12, 2026
- CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease in Subjects Who Completed CYS-004PHASE3 · COMPLETED · started Jan 4, 2021ClinicalTrials.gov NCT04523142 · fetched Nov 12, 2026
- ESSENCE 2: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)PHASE3 · COMPLETED · started Dec 5, 2020ClinicalTrials.gov NCT04523129 · fetched Nov 12, 2026
- Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)PHASE2 · COMPLETED · started Jan 3, 2018ClinicalTrials.gov NCT03333057 · fetched Nov 12, 2026
- CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)PHASE2_PHASE3 · COMPLETED · started Oct 19, 2017ClinicalTrials.gov NCT03292809 · fetched Nov 12, 2026
- CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED)PHASE2 · COMPLETED · started Jan 1, 2016ClinicalTrials.gov NCT02617667 · fetched Nov 12, 2026